Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Immune Pharmaceuticals Inc. (IMNPQ) had Debt to Capital Ratio of 0.51 for the most recently reported fiscal quarter, ending 2018-09-30.
| Income Statement Financials | |
-- |
|
$-9.67M |
|
-- |
|
-- |
|
$3.70M |
|
$-3.70M |
|
$-0.43M |
|
$-4.13M |
|
$-4.14M |
|
$-4.13M |
|
$-4.13M |
|
$-4.13M |
|
$-4.14M |
|
$-3.70M |
|
$-2.99M |
|
39.51M |
|
39.51M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$0.36M |
|
$0.10M |
|
$20.35M |
|
$20.72M |
|
$14.86M |
|
$0.87M |
|
$5.01M |
|
$19.87M |
|
$0.84M |
|
$-4.31M |
|
$0.84M |
|
44.96M |
|
| Cash Flow Statement Financials | |
$-8.34M |
|
$-0.10M |
|
$1.74M |
|
$6.78M |
|
$0.08M |
|
$-6.70M |
|
$0.17M |
|
-- |
|
$-0.16M |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.51 |
9.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-490.73% |
|
95.80% |
|
-19.95% |
|
-241.36% |
|
$0.02 |
|
$-0.21 |
|
$-0.21 |
|